Table 2. Demographic Data of Modified Traditional Cohort and MDC .
Characteristic | Traditional Clinic (n = 50) |
Multidisciplinary Clinic (n = 68) |
Difference, % (95% CI) |
---|---|---|---|
Age, mean (SD), y | 63.5 (10.2) | 60.8 (8.9) | 2.7 (−0.8 to 6.2)a |
Sex, No. (%) | |||
Male | 37 (74) | 60 (88) | −16 (−31 to −1) |
Female | 13 (26) | 8 (12) | |
Median distance from clinic (range), kmb | 37 (5 to 1520) | 54 (3 to 477) | −3 (−14 to 10)c |
Adult Comorbidity Evaluation-27 scores, No. (%) | |||
None | 5 (10) | 18 (26) | −16 (−29 to −3) |
Mild | 30 (60) | 23 (34) | 26 (8 to 44) |
Moderate | 7 (14) | 21 (31) | −17 (−32 to −2) |
Severe | 8 (16) | 6 (9) | 7 (−5 to 19) |
Primary tumor site | |||
Oropharynx | 30 (60) | 57 (84) | −24 (−40 to −8) |
Otherd | 20 (40) | 11 (16) | |
Tumor stage | |||
1 | 4 (8) | 1 (2) | 6 (−2 to 14) |
2 | 3 (6) | 3 (4) | 2 (−6 to 10) |
3 | 5 (10) | 13 (19) | −7 (−20 to 6) |
4 | 38 (76) | 51 (75) | −1 (−17 to 15) |
Treatment type | |||
Surgery alone | 7 (14) | 7 (10) | 4 (−8 to 16) |
Radiotherapy | 0 | 1 (2) | −1 (−4 to 2) |
Chemotherapy and radiotherapy | 19 (38) | 19 (28) | 0 (−7 to 27) |
Palliative chemotherapy | 5 (10) | 7 (10) | 0 (−11 to 11) |
Surgery and adjuvant | 13 (26) | 29 (43) | −17 (−34 to 0) |
Neoadjuvant and chemotherapy and radiotherapy | 6 (12) | 5 (7) | 5 (−6 to 16) |
Mean difference and 95% CI calculated for age.
To convert to miles, divide by 1.6.
Median difference with 95% CI.
Other sites include 9 cases in the hypopharynx, 6 in the supraglottis, 8 in the glottis, 2 in the subglottis, 2 in the sinonasal tract, and 2 with unknown primary tumor sites.